1
16
S.S. Cotrin et al. / Molecular & Biochemical Parasitology 187 (2013) 111–116
the results obtained with the mimetic-HK peptide. Our results
demonstrated that the well-known inhibitory effects of the two
cystatin-like domains of kininogen on falcipains [7] are not suffi-
cient to block FP-2 and FP-3 activity but can be responsible for the
high enzyme concentrations required to yield a sufficient amount
of kinins for detection, particularly in a very sensitive method
such as an radioimmunoassay. Bagnaresi et al. [18] verified that
HK fragments resulting from FP-2 and FP-3 cleavage were bio-
logically active and were able to promote the contraction of the
isolated guinea pig ileum, which was prevented by the B2 recep-
tor antagonist HOE-140. When HK was incubated with FP-2 and
FP-3 in the presence of the specific cysteine protease inhibitor E-
[15] Schechter I, Berger A. On the size of the active site in proteases. I. Papain.
Biochemical and Biophysical Research Communications 1967;27:157–62.
[
16] Del Nery E, Juliano MA, Lima AP, Scharfstein J, Juliano L. Kininogenase activity
by the major cysteinyl proteinase (cruzipain) from Trypanosoma cruzi. Journal
of Biological Chemistry 1997;272:25713–8.
[
17] St Hilaire PM, Alves LC, Herrera F, Renil M, Sanderson SJ, Mottram JC, et al.
Solid-phase library synthesis, screening, and selection of tight-binding reduced
peptide bond inhibitors of a recombinant Leishmania mexicana cysteine pro-
tease B. Journal of Medicinal Chemistry 2002;45:1971–82.
[18] Bagnaresi P, de Barros NM, Assis DM, Melo PM, Fonseca RG, Juliano MA, et al.
Intracellular proteolysis of kininogen by malaria parasites promotes release of
active kinins. Malar Journal 2012;11:156.
[19] Sijwali PS, Brinen LS, Rosenthal PJ. Systematic optimization of expression and
refolding of the Plasmodium falciparum cysteine protease falcipain-2. Protein
Expression and Purification 2001;22:128–34.
[
20] Barrett AJ, Kembhavi AA, Brown MA, Kirschke H, Knight CG, Tamai M, et al.
l-trans-Epoxysuccinyl-leucylamido(4-guanidino)butane (E-64) and its ana-
logues as inhibitors of cysteine proteinases including cathepsins B, H and L.
Bioremediation Journal 1982;201:189–98.
6
4, the contraction response was ablated. The answer obtained in
this pharmacological system, together with our radioimmunoassay
data demonstrate that active kinins are generated as a result of HK
processing by falcipains.
Taken together, the comparative specificity studies and the
description of the kininogenase activity of the recombinant
enzymes from P. falciparum FP-2 and FP-3 may contribute to a better
understanding of the role of these enzymes in parasite biology.
[
21] Hirata IY, Cezari MHS, Nakaie CR, Boschcov P, Ito AS, Juliano MA, et al. Internally
quenched fluorogenic protease substrates: solid-phase synthesis and fluores-
cence spectroscopy of peptides contaning orto-aminobenzoyl/dinitrophenyl
groups as donnor–acceptor pairs. Letters in Peptide Science 1994;1:9.
22] Shimamoto K, Ando T, Nakao T, Tanaka S, Sakuma M, Miyahara M. A sensitive
radioimmunoassay method for urinary kinins in man. Journal of Laboratory
and Clinical Medicine 1978;91:721–8.
[
[
23] Turk D, Guncar G, Podobnik M, Turk B. Revised definition of substrate bind-
ing sites of papain-like cysteine proteases. Biological Chemistry 1998;379:
Acknowledgments
137–47.
[
[
24] Greenwood B, Mutabingwa T. Malaria in 2002. Nature 2002;415:670–2.
25] Farias SL, Gazarini ML, Melo RL, Hirata IY, Juliano MA, Juliano L, et al. Cysteine-
This work was supported by the Brazilian Agencies Funda c¸ ão de
Amparo à Pesquisa do Estado de São Paulo (FAPESP) and Conselho
Nacional de Desenvolvimento Científico e Tecnológico (CNPq).
2
+
protease activity elicited by Ca stimulus in Plasmodium. Molecular and
Biochemical Parasitology 2005;141:71–9.
[26] Rosenthal PJ. Hydrolysis of erythrocyte proteins by proteases of malaria para-
sites. Current Opinion in Hematology 2002;9:140–5.
[
27] Ramjee MK, Flinn NS, Pemberton TP, Quibell M, Wang Y, Watts JP. Substrate
mapping and inhibitor profiling of falcipain-2, falcipain-3 and berghepain-2:
implications for peptidase anti-malarial drug discovery. Bioremediation Jour-
nal 2006;399:47–57.
References
[1] Snow RW, Guerra CA, Noor AM, Myint HY, Hay SI. The global distribution of
clinical episodes of Plasmodium falciparum malaria. Nature 2005;434:214–7.
[2] Feachem RG, Phillips AA, Hwang J, Cotter C, Wielgosz B, Greenwood BM, et al.
Shrinking the malaria map: progress and prospects. Lancet 2010;376:1566–78.
[3] Sijwali PS, Shenai BR, Gut J, Singh A, Rosenthal PJ. Expression and characteriza-
tion of the Plasmodium falciparum haemoglobinase falcipain-3. Bioremediation
Journal 2001;360:481–9.
[28] Wang SX, Pandey KC, Somoza JR, Sijwali PS, Kortemme T, Brinen LS, et al.
Structural basis for unique mechanisms of folding and hemoglobin binding
by a malarial protease. Proceedings of the National Academy of Sciences of the
United States of America 2006;103:11503–8.
[29] Hogg T, Nagarajan K, Herzberg S, Chen L, Shen X, Jiang H, et al. Struc-
tural and functional characterization of Falcipain-2, a hemoglobinase from
the malarial parasite Plasmodium falciparum. Journal of Biological Chemistry
2006;281:25425–37.
[30] Kerr ID, Lee JH, Pandey KC, Harrison A, Sajid M, Rosenthal PJ, et al. Structures
of falcipain-2 and falcipain-3 bound to small molecule inhibitors: implications
for substrate specificity. Journal of Medicinal Chemistry 2009;52:852–7.
[31] Scott CF, Whitaker EJ, Hammond BF, Colman RW. Purification and char-
acterization of a potent 70-kDa thiol lysyl-proteinase (Lys-gingivain) from
Porphyromonas gingivalis that cleaves kininogens and fibrinogen. Journal of
Biological Chemistry 1993;268:7935–42.
[
4] Subramanian S, Sijwali PS, Rosenthal PJ. Falcipain cysteine proteases require
bipartite motifs for trafficking to the Plasmodium falciparum food vacuole. Jour-
nal of Biological Chemistry 2007;282:24961–9.
[
5] Sijwali PS, Kato K, Seydel KB, Gut J, Lehman J, Klemba M, et al. Plasmodium
falciparum cysteine protease falcipain-1 is not essential in erythrocytic stage
malaria parasites. Proceedings of the National Academy of Sciences of the
United States of America 2004;101:8721–6.
[
6] Shenai BR, Sijwali PS, Singh A, Rosenthal PJ. Characterization of native and
recombinant falcipain-2, a principal trophozoite cysteine protease and essen-
tial hemoglobinase of Plasmodium falciparum. Journal of Biological Chemistry
[32] Herwald H, Collin M, Muller-Esterl W, Bjorck L. Streptococcal cysteine pro-
2
000;275:29000–10.
teinase releases kinins:
a virulence mechanism. Journal of Experimental
[
[
7] Singh N, Sijwali PS, Pandey KC, Rosenthal PJ. Plasmodium falciparum: bio-
chemical characterization of the cysteine protease falcipain-2 . Experimental
Parasitology 2006;112:187–92.
8] Pandey KC, Wang SX, Sijwali PS, Lau AL, McKerrow JH, Rosenthal PJ. The
Plasmodium falciparum cysteine protease falcipain-2 captures its substrate,
hemoglobin, via a unique motif. Proceedings of the National Academy of Sci-
ences of the United States of America 2005;102:9138–43.
Medicine 1996;184:665–73.
ꢀ
[33] Nery ED, Juliano MA, Meldal M, Svendsen I, Scharfstein J, Walmsley A,
et al. Characterization of the substrate specificity of the major cysteine
protease (cruzipain) from Trypanosoma cruzi using a portion-mixing combi-
natorial library and fluorogenic peptides. Bioremediation Journal 1997;323(Pt
2):427–33.
[34] Cordova M, Jara J, Del Nery E, Hirata IY, Araujo MS, Carmona AK, et al. Char-
acterization of two cysteine proteinases secreted by Fasciola hepatica and
demonstration of their kininogenase activity. Molecular and Biochemical Para-
sitology 2001;116:109–15.
[35] Tella A, Maegraith BG. Studies on bradykinin and bradykininogen in malaria.
Annals of Tropical Medicine and Parasitology 1966;60:304–17.
[36] Subramanian S, Hardt M, Choe Y, Niles RK, Johansen EB, Legac J, et al.
Hemoglobin cleavage site-specificity of the Plasmodium falciparum cysteine
proteases falcipain-2 and falcipain-3. PLoS One 2009;4:e5156.
[37] Sivaraman KK, Oellig CA, Huynh K, Atkinson SC, Poreba M, Perugini MA, et al.
X-ray crystal structure and specificity of the plasmodium falciparum malaria
aminopeptidase PfM18AAP. Journal of Molecular Biology 2012;422:495–507.
[38] Poreba M, McGowan S, Skinner-Adams TS, Trenholme KR, Gardiner DL,
Whisstock JC, et al. Fingerprinting the substrate specificity of M1 and
M17 aminopeptidases of human malaria, Plasmodium falciparum. PLoS One
2012;7:e31938.
[39] Dalal S, Ragheb DR, Klemba M. Engagement of the S1, S1 and S2 subsites drives
efficient catalysis of peptide bond hydrolysis by the M1-family aminopep-
tidase from Plasmodium falciparum. Molecular and Biochemical Parasitology
2012;183:70–7.
[
9] Pandey KC, Sijwali PS, Singh A, Na BK, Rosenthal PJ. Independent intramolecular
mediators of folding, activity, and inhibition for the Plasmodium falciparum cys-
teine protease falcipain-2. Journal of Biological Chemistry 2004;279:3484–91.
[
[
[
10] Greenbaum DC, Baruch A, Grainger M, Bozdech Z, Medzihradszky KF, Engel J,
et al. A role for the protease falcipain 1 in host cell invasion by the human
malaria parasite. Science 2002;298:2002–6.
11] Eksi S, Czesny B, Greenbaum DC, Bogyo M, Williamson KC. Targeted disruption
of Plasmodium falciparum cysteine protease, falcipain 1, reduces oocyst produc-
tion, not erythrocytic stage growth. Molecular Microbiology 2004;53:243–50.
12] Malhotra P, Dasaradhi PV, Kumar A, Mohmmed A, Agrawal N, Bhatnagar
RK, et al. Double-stranded RNA-mediated gene silencing of cysteine pro-
teases (falcipain-1 and -2) of Plasmodium falciparum. Molecular Microbiology
2
002;45:1245–54.
[
13] Sijwali PS, Koo J, Singh N, Rosenthal PJ. Gene disruptions demonstrate indepen-
dent roles for the four falcipain cysteine proteases of Plasmodium falciparum.
Molecular and Biochemical Parasitology 2006;150:96–106.
ꢀ
ꢀ
[
14] Pandey KC, Singh N, Arastu-Kapur S, Bogyo M, Rosenthal PJ. Falstatin, a cysteine
protease inhibitor of Plasmodium falciparum, facilitates erythrocyte invasion.
PLoS Pathogens 2006;2:e117.